首页> 美国卫生研究院文献>Antimicrobial Resistance and Infection Control >Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis
【2h】

Costs of outpatient and inpatient MRSA screening and treatment strategies for patients at elective hospital admission - a decision tree analysis

机译:择期住院患者的门诊和住院MRSA筛查成本和治疗策略-决策树分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundNosocomial infections are among the most common complications in hospitals. A major part is caused by multidrug-resistant organisms (MDRO). MRSA is still the most prominent and frequent MDRO. The early detection of carriers of multidrug-resistant bacteria is an effective measure to reduce nosocomial infections caused by MDRO. For patients who are planning to go to the hospital, an outpatient screening for MDRO and pre-hospital decolonization is recommended. However, the effectiveness of such pre-admission MDRO management in preparation for a planned hospital stay has not yet been sufficiently scientifically examined from an economic perspective.
机译:背景医院感染是医院最常见的并发症之一。大部分是由耐多药生物(MDRO)引起的。 MRSA仍然是最著名和最常见的MDRO。早期发现耐多药细菌的载体是减少由MDRO引起的医院感染的有效措施。对于计划去医院的患者,建议对MDRO和院前非殖民化进行门诊检查。但是,从经济的角度出发,尚未对这种入院前的MDRO管理在准备计划的住院住宿方面的有效性进行充分的科学检验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号